Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 18;14(1):20.
doi: 10.1038/s41387-024-00278-2.

An algorithm for the use of anti-obesity medications

Fereshteh Dehghani  1 , Mitra Ali Ahmadi #  1 , Marleigh Hefner #  1 , Gaurav Kudchadkar #  1 , Wasiuddin Najam #  2 , Masoud Nateqi #  1 , Md Abu Bakkar Siddik #  1 , Holli Booe  3 , Nikhil V Dhurandhar  4
Affiliations
Review

An algorithm for the use of anti-obesity medications

Fereshteh Dehghani et al. Nutr Diabetes. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

NVD has received investigator initiated grant and consultation from Novo Nordisk in the past for projects unconnected with this manuscript.

Figures

Fig. 1
Fig. 1. Considerations for condition-specific use of anti-obesity medications.
Arrow styles indicate the BMI and age groups approved for receiving obesity medications listed below.
See this image and copyright information in PMC

References

    1. Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin. 2018;102:183–97. - PMC - PubMed
    1. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342–62. doi: 10.1210/jc.2014-3415. - DOI - PubMed
    1. Henderson K, Lewis, Sloan CE, Bessesen DH, Arterburn D. Effectiveness and safety of drugs for obesity. BMJ. 2024;384:e072686. doi: 10.1136/bmj-2022-072686. - DOI - PubMed
    1. Daigle KM, Gang CH, Kopping MF, Gadde KM. Relationship between perceptions of obesity causes and weight loss expectations among adults. J Nutr Educ Behav. 2019;51:86–90. doi: 10.1016/j.jneb.2018.08.015. - DOI - PMC - PubMed
    1. Winslow DH, Bowden CH, DiDonato KP, McCullough PA. A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults. Sleep. 2012;35:1529–39. doi: 10.5665/sleep.2204. - DOI - PMC - PubMed

Substances